The original version of this Article contained typographical errors, where the unit 'ng/ml' was incorrectly given as 'pg/ml' . As a result, in the Abstract, "The cut-off value of H-FABP, 4.143 pg/mL, was determined using receiver operating characteristic curves. " now reads:
9:4838 | https://doi.org/10.1038/s41598-018-36737-x www.nature.com/scientificreports www.nature.com/scientificreports/ "The cut-off value of H-FABP (4.143 ng/mL) was determined by receiver operating characteristic curves (ROC) curve analysis (Fig. 1 ) between the patients with and without CV events from the blood sample obtained at enrollment. "
In the Discussion section, "This study is the first prospective cohort study to demonstrate that a higher serum H-FABP level (≧4.143 pg/ mL) is an independent predictor for CV events, particularly for cardio-and cerebrovascular death and acute heart failure-related hospitalizations in patients with SCHD. " now reads:
"This study is the first prospective cohort study to demonstrate that a higher serum H-FABP level (≧4.143 ng/ mL) is an independent predictor for CV events, particularly for cardio-and cerebrovascular death and acute heart failure-related hospitalizations in patients with SCHD. "
In Table 2 , the column headings 'H-FABP < 4.143 pg/mL' and 'H-FABP ≧ 4.143 pg/mL' have been corrected to 'H-FABP < 4.143 ng/mL' and 'H-FABP ≧ 4.143 ng/mL' , respectively.
In Table 3 , the column headings 'H-FABP <4.143pg/mL, (n=843)' and 'H-FABP ≧4.143pg/mL, (n=228)' have been corrected to 'H-FABP <4.143ng/mL, (n=843)' and 'H-FABP ≧4.143ng/mL, (n=228)' , respectively.
In the legend of Figure 2 , "Kaplan-Meier survival curves analysis showing total cardiovascular (CV) event-free rate (a), CV or cerebrovascular death-free rate (b), acute heart failure hospitalization-free rate (c), and total CV event-free rate except for angina-related hospitalization (d) in patients with serum H-FABP ≧4.143 pg/mL and H-FABP <4.143 pg/mL (all p < 0.001). " now reads:
"Kaplan-Meier survival curves analysis showing total cardiovascular (CV) event-free rate (a), CV or cerebrovascular death-free rate (b), acute heart failure hospitalization-free rate (c), and total CV event-free rate except for angina-related hospitalization (d) in patients with serum H-FABP ≧4.143 ng/mL and H-FABP <4.143 ng/mL (all p < 0.001). "
In addition, the original version of this Article contained typographical errors, where the unit 'g/dL' was incorrectly given as 'mg/dL' . As a result, in Table 2 , the row heading 'Hemoglobin, mg/dL' has been corrected to 'Hemoglobin, g/dL' . These errors have now been corrected in the HTML and PDF versions of the Article.
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